Mobetron - Intraoperative Radiation Therapy (IORT) System
From IORT
Our flagship product—the Intraop® Mobetron®—is used by the leading cancer physicians in the best hospitals, clinics and academic centers in the world. The Mobetron is the first mobile, self-shielded electron-beam linear accelerator (LINAC) machine designed to deliver Intraoperative Radiation Therapy (IORT) to cancer patients during surgery. This innovation brings safe, reliable and portable radiation to the operating room without the need for costly shielding renovations or retrofits. And in turn, Mobetron underscores IntraOp’s commitment to providing a solution designed to maximize cost effectiveness and reduce risk for cancer centers and their patients alike.
Products Details
In modern treatment, nearly every leading cancer program uses some form of radiation to augment surgery. Historically, radiation therapy involved a time-consuming and imprecise external procedure that put a patient’s healthy tissue and organs at greater risk. Indirect doses of radiation were administered before or after the surgical procedure. Sometimes it was both. Intraoperative Radiation Therapy (IORT) revolutionized that traditional model by administering radiation during the surgical process. It’s safer, more accurate and it saves the hospital and the patient a considerable amount of time. And time is money. Beyond that, clinical data confirms that successful outcomes with IORT are simply more consistent. The advantages are clear.
Why Electron IORT?
As effective as it is, IORT still has its share of critics. But those issues are largely rooted in bygone misperceptions related to patient transport and the considerable investment attributed to staff and capital equipment. The idea of radiation in the operating room previously required cost-prohibitive retrofits to ensure safe operation and shielding. During that time, IORT was based on proton-beam technologies and closely-related photon therapies. Fortunately, that era is over.
The game changed when IntraOp introduced electrons to the equation. Targeted radiation using electron IORT delivered by a self-shielded unit meant that safe radiation could be brought to the operating room and in turn, to the patient. That innovation enabled portability and further reduced overall costs while improving dose distribution and consistency with more rapid fall-off rates of radiation and lesser damage to surrounding normal tissues. Shorter treatment times and less invasive surgery now equates to greater patient comfort during treatment and shorter recovery times with improved cosmesis following surgery.
With the IntraOp® Mobetron®, the next generation in cancer treatment is here. Now.
Is electron radiation therapy the best solution in every instance? No. There are many effective approaches also proven to treat cancer. But electron-beam Intraoperative Radiation Therapy should be an integrated component in every comprehensive cancer program. The data supports the claim. Electron-beam IORT works and it is made better with Mobetron.
- Preserves healthy tissue:
A precise dose allows concentrated radiation only to the tumor bed. Critical organs such as heart and lungs are unaffected. - Decreases treatment times:
Treatment generally requires only a few minutes, rather than weeks of pre- and post-surgery radiation sessions. - Delivers a boost:
As a boost strategy, electron IORT augments traditional radiation with fewer complications and fewer instances of recurrence. - Provides maximum effect:
Concentrated dose of radiation to a tumor site after it is removed assists in destroying residual microscopic tumor cells.
Consider the scene before the Mobetron: a patient undergoing surgery is required transport to a shielded radiation bunker only to be returned after treatment for the remainder of the surgery. The method was inefficient for oncologists and it added costs for the hospital. Worse, it introduced greater risk for the patient.
Fast forward. By making electrons portable, the Mobetron leverages the advantages of electron IORT without sacrificing effectiveness. Radiation and surgical oncologists are now enabled to work together to pinpoint the exact area requiring radiation and immediately deliver high doses directly to the affected tissue during cancer surgery. Healthy tissue and surrounding organs remain unaffected. Portability means that the Mobetron IORT machine can easily be moved between existing operating rooms without investing in costly renovations to accommodate traditional unshielded radiation therapy devices. The treatment is brought to the patient. The procedure is completed in a fraction of the time with fewer side effects and lower rates of recurrence. Most importantly, the patient can go on living. Longer.
Treatment with the Mobetron has been shown to be successful for the following cancers:
- Breast Cancer
- Breast Cancer (Single-Fraction APBI)
- Breast Cancer (Boost)
- Pancreatic Cancer
- Colorectal Cancer
- Gynecological Cancer
- Head and Neck Cancers
- Sarcomas
Benefits
Proven success with multiple indications of cancer
Offers flexible movement within and between OR suites
Electron-beam IORT delivers radiation to only involved tissue
Two minutes during surgery replaces weeks of therapy
Direct dose to tumor bed avoids healthy tissue and organs
Proven success and increased survival rates
Avoids adding costly shielding to the OR
Mobetron is designed and built in Silicon Valley California
Let us show you the Mobetron value proposition
Customer reviews
No reviews were found for Mobetron - Intraoperative Radiation Therapy (IORT) System. Be the first to review!